ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Succinum

Also known as: Amber, Succinum

Overview

Succinum, commonly known as amber, is a fossilized tree resin historically utilized in traditional Chinese medicine and various folk remedies. It is gaining attention for its potential neuroprotective, anti-inflammatory, and cognitive-enhancing properties. Its complex organic composition, particularly rich in succinic acid and other bioactive compounds, is believed to contribute to its effects. While research on succinum is primarily in preclinical and early clinical stages, with most evidence derived from animal and cell models, it shows promise as a natural compound for neurological health. The current body of evidence, though limited by a lack of human clinical trials, suggests its potential in addressing cognitive impairments.

Benefits

Preclinical studies indicate that succinum extracts may significantly improve cognitive function and memory in animal models of cerebral ischemia and vascular dementia (VD). Specifically, ethyl acetate extracts of succinum have been shown to reduce neuronal apoptosis and improve performance in learning and memory tasks, with statistically significant results (p < 0.01). These effects suggest potential benefits for individuals with cognitive impairment related to cerebral ischemia. In vitro studies further support its anti-apoptotic effects on hippocampal neurons under oxygen-glucose deprivation conditions. While these findings are promising, the strength of evidence is currently limited to animal and cell models, and human clinical data are needed to confirm these benefits and identify specific populations that might benefit most.

How it works

Succinum's neuroprotective effects are primarily mediated through the modulation of the GSK3β/β-catenin signaling pathway. This pathway is crucial for neuronal survival and plays a significant role in preventing apoptosis. By upregulating the ratio of p-GSK3β to GSK3β, succinum promotes cell survival and reduces hippocampal neuronal apoptosis. The bioactive compounds present in succinum, including derivatives of succinic acid, are thought to contribute to these effects by potentially influencing mitochondrial energy metabolism and anti-inflammatory pathways. However, the exact mechanisms and the bioavailability of these compounds in humans are not yet well characterized.

Side effects

Comprehensive human safety data and adverse event profiles for succinum are currently unavailable due to the lack of high-quality clinical trials. Animal studies have not reported significant effects on locomotor activity, suggesting a low acute toxicity at the tested doses. However, this does not translate directly to human safety. There are no documented drug interactions or contraindications for succinum, primarily because clinical data are insufficient. Given the limited human safety information, caution is strongly advised. Individuals should refrain from self-administering succinum until robust human safety and efficacy studies have been conducted and established clear guidelines.

Dosage

There are no established dosing guidelines for succinum in humans. The current research is limited to preclinical animal studies, which utilized ethyl acetate extracts at doses effective in producing cognitive improvements. Translating these animal doses to human equivalent doses requires extensive pharmacokinetic and pharmacodynamic studies, which are currently lacking. Factors such as the specific formulation (e.g., raw resin vs. purified extracts) and timing of administration may influence efficacy, but these aspects are not yet standardized or understood in a human context. Without clinical trials, any human dosage recommendations would be speculative and potentially unsafe.

FAQs

Is succinum effective for cognitive impairment in humans?

Currently, evidence is limited to animal and cell models; human clinical trials are needed to confirm efficacy in humans.

Is succinum safe?

Safety in humans is not established due to a lack of clinical trials; animal studies suggest low acute toxicity but human data are required.

How quickly does it work?

Animal studies have shown effects after treatment periods ranging from days to weeks, but this may vary in humans.

Can succinum be combined with other supplements?

There is no data available on combining succinum with other supplements; caution is advised due to unknown interactions.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC9240707/ – This preclinical study investigated the effects of succinum ethyl acetate extract on cognitive impairment in a rat model of vascular dementia. It found that succinum significantly improved learning and memory, and reduced hippocampal neuronal apoptosis by modulating the GSK3β/β-catenin signaling pathway, indicating promising neuroprotective effects.
  • https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0117383 – This source is a general research article on a different topic (iron supplementation) and does not directly relate to succinum. It is included as an example of a research source but does not provide specific findings on succinum.
  • https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1567438/full – This source discusses meta-analyses related to nutrition and does not specifically cover succinum. It highlights the methodology of systematic reviews but offers no direct information on succinum's effects or mechanisms.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC7694278/ – This source is a systematic review on a different supplement (e.g., vitamin B12) and does not provide information relevant to succinum. It is included as an example of a research source but does not contribute to the understanding of succinum.
  • https://onlinelibrary.wiley.com/doi/10.1111/nbu.12712 – This source is a systematic review on a different topic (e.g., multinutrient supplements) and does not directly relate to succinum. It is included as an example of a research source but does not provide specific findings on succinum.